167 related articles for article (PubMed ID: 24339132)
1. CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620.
Kim KH; Yoo BC; Kim WK; Hong JP; Kim K; Song EY; Lee JY; Cho JY; Ku JL
Electrophoresis; 2014 Feb; 35(4):522-32. PubMed ID: 24339132
[TBL] [Abstract][Full Text] [Related]
2. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity.
Corbo C; Orrù S; Gemei M; Noto RD; Mirabelli P; Imperlini E; Ruoppolo M; Vecchio LD; Salvatore F
Proteomics; 2012 Jun; 12(12):2045-59. PubMed ID: 22623141
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.
Feng JM; Miao ZH; Jiang Y; Chen Y; Li JX; Tong LJ; Zhang J; Huang YR; Ding J
Cancer Biol Ther; 2012 Dec; 13(14):1396-406. PubMed ID: 22954703
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells.
Deng YH; Pu XX; Huang MJ; Xiao J; Zhou JM; Lin TY; Lin EH
Chin J Cancer; 2010 Sep; 29(9):810-5. PubMed ID: 20800023
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of CD133(+) human colon cancer SW620 cells.
Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
[TBL] [Abstract][Full Text] [Related]
6. CD133(-) cells, derived from a single human colon cancer cell line, are more resistant to 5-fluorouracil (FU) than CD133(+) cells, dependent on the β1-integrin signaling.
Hongo K; Tanaka J; Tsuno NH; Kawai K; Nishikawa T; Shuno Y; Sasaki K; Kaneko M; Hiyoshi M; Sunami E; Kitayama J; Takahashi K; Nagawa H
J Surg Res; 2012 Jun; 175(2):278-88. PubMed ID: 21601882
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
8. Chemoresistance of CD133(+) colon cancer may be related with increased survivin expression.
Lee MR; Ji SY; Mia-Jan K; Cho MY
Biochem Biophys Res Commun; 2015 Jul; 463(3):229-34. PubMed ID: 26002465
[TBL] [Abstract][Full Text] [Related]
9. Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620.
Tentes IK; Schmidt WM; Krupitza G; Steger GG; Mikulits W; Kortsaris A; Mader RM
Exp Cell Res; 2010 Nov; 316(19):3172-81. PubMed ID: 20849845
[TBL] [Abstract][Full Text] [Related]
10. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
[TBL] [Abstract][Full Text] [Related]
11. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer.
Puglisi MA; Sgambato A; Saulnier N; Rafanelli F; Barba M; Boninsegna A; Piscaglia AC; Lauritano C; Novi ML; Barbaro F; Rinninella E; Campanale C; Giuliante F; Nuzzo G; Alfieri S; Doglietto GB; Cittadini A; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():55-62. PubMed ID: 19530513
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells.
Zhu Y; Yu J; Wang S; Lu R; Wu J; Jiang B
Oncol Rep; 2014 Dec; 32(6):2437-44. PubMed ID: 25230779
[TBL] [Abstract][Full Text] [Related]
14. Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.
Puglisi MA; Barba M; Corbi M; Errico MF; Giorda E; Saulnier N; Boninsegna A; Piscaglia AC; Carsetti R; Cittadini A; Gasbarrini A; Sgambato A
J Pathol; 2011 Oct; 225(2):305-14. PubMed ID: 21826669
[TBL] [Abstract][Full Text] [Related]
15. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
[TBL] [Abstract][Full Text] [Related]
16. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
[TBL] [Abstract][Full Text] [Related]
17. A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy.
Mao Q; Zhang Y; Fu X; Xue J; Guo W; Meng M; Zhou Z; Mo X; Lu Y
J Cancer Res Clin Oncol; 2013 Feb; 139(2):211-22. PubMed ID: 23052691
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
19. Cytometric profiling of CD133+ cells in human colon
carcinoma cell lines identifies a common core phenotype
and cell type-specific mosaics.
Gemei M; Di Noto R; Mirabelli P; Del Vecchio L
Int J Biol Markers; 2013 Sep; 28(3):267-73. PubMed ID: 23709346
[TBL] [Abstract][Full Text] [Related]
20. Comparison of nucleostemin gene expression in CD133+ and CD133- cell population in colon cancer cell line HT29.
Zia-Jahromi N; Hejazi SH; Panjepour M; Parivar K; Gharagozloo M
J Cancer Res Ther; 2014; 10(1):68-72. PubMed ID: 24762489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
